Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients

Home » Advanced Search

Search Results for Abatacept

Perform Another (Advanced) Search

Related Words: abatacept

187 Results within Entire Site

Limit results to show:

1.  Newly Approved Drug Therapies (888) Orencia (abatacept), Bristol-Myers Squibb,
...Newly Approved Drug Therapies (888) Orencia (abatacept), Bristol-Myers Squibb, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Orencia (abatacept) Company: Bristol-Myers Squibb Approval Status: Approved December 2005 Treatment Area: Rheumatoid Arthritis General Information ...
View Page

2.  Newly Approved Drug Therapies (983) Orencia (abatacept), Bristol-Myers Squibb,
...Newly Approved Drug Therapies (983) Orencia (abatacept), Bristol-Myers Squibb, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Orencia (abatacept) Company: Bristol-Myers Squibb Approval Status: Approved April 2008 Treatment Area: Juvenile Idiopathic Arthritis General ...
View Page

3.  Study Posting (3162) Trial #150211, Rheumatoid Arthritis, Rochester, NY
...with Rheumatoid Arthritis The purpose of this study is to demonstrate that subcutaneous injections of abatacept (Orencia) are as effective as intravenous infusions of abatacept (Orencia) when used together with methotrexate in subjects with active rheumatoid arthritis. Like intravenous administration ...
View Page

4.  Study Posting (2788) Trial #152884, Lupus, Dallas, TX
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

5.  Study Posting (2788) Trial #155986, Lupus, Philadelphia, PA
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

6.  Study Posting (2788) Trial #152883, Lupus, Pittsburgh, NC
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

7.  Study Posting (2788) Trial #155985, Lupus, Rochester, NY
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

8.  Study Posting (2788) Trial #152879, Lupus, Manhasset, NY
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

9.  Study Posting (2788) Trial #154763, Lupus, Detroit, MI
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

10.  Study Posting (2788) Trial #155984, Lupus, Boston, MA
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

11.  Study Posting (2788) Trial #157591, Lupus, Chicago, IL
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

12.  Study Posting (2788) Trial #152878, Lupus, Miami, FL
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

13.  Study Posting (2788) Trial #157592, Lupus, Birmingham, AL
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

14.  Study Posting (2788) Trial #152881, Lupus, Oklahoma City, OK
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

15.  Study Posting (2788) Trial #152882, Lupus, Chapel Hill, NC
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

16.  Study Posting (2788) Trial #152880, Lupus, New York, NY
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

17.  Study Posting (2788) Trial #152268, Lupus, San Francisco, CA
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

18.  Study Posting (2788) Trial #152876, Lupus, Los Angeles, CA
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

19.  Study Posting (2788) Trial #152877, Lupus, La Jolla, CA
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page

20.  Study Posting (2788) Trial #153229, Kidney Disease, Philadelphia, PA
...a condition called "lupus nephritis"). The study is testing whether adding the experimental medication called "abatacept" (pronounced ‘AB-uh-TA-sept) to a standard cyclophosphamide (Cytoxan) treatment regimen is more effective in improving lupus nephritis than the cyclophosphamide regimen by itself. The study drug abatacept has been approved by the FDA for the treatment of moderate to severe rheumatoid arthritis ...
View Page


Jobson Medical Information

Copyright © 2008 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.